Wu, Yu-tuan Li, Xin Liu, Zi-li Xu, Zhou Dai, Wei Zhang, Ke Wu, Jiu-song Arshad, Bilal Wu, Kai-nan Kong, Ling-quan Risk ratio of HBV reactivation comparing antiviral prophylaxis with non-prophylaxis in HBsAg-positive lung cancer patients. <p>Risk ratio of HBV reactivation comparing antiviral prophylaxis with non-prophylaxis in HBsAg-positive lung cancer patients.</p> hepatitis B virus reactivation;RR;hepatitis B virus;hepatitis B surface antigen;HBV reactivation;lung cancer patients;CI;evidences support HBV screening;meta-analysis Background Antiviral drugs;chemotherapy disruption;prophylaxi;incidence;HBsAg-positive lung cancer patients;lung cancer chemotherapy 2017-06-22
    https://plos.figshare.com/articles/figure/Risk_ratio_of_HBV_reactivation_comparing_antiviral_prophylaxis_with_non-prophylaxis_in_HBsAg-positive_lung_cancer_patients_/5138032
10.1371/journal.pone.0179680.g003